Minimal-change glomerulonephritis in chronic lymphocytic leukemia

Minimal-change glomerulonephritis in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) in association with glomerulonephritis (GN) and renal failure is a serious problem in terms of therapy. The paper reports a clinical case of a 64-year-old female patient with Binet stage C CLL accompanied by minimal-change GN complicated by nephrotic syndrome and t...

Full description

Bibliographic Details
Main Authors:	B T Dzhumabaeva, L S Biryukova, E P Golitsyna, V A Varshavsky
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2015-12-01
Series:	Терапевтический архив
Subjects:	chronic lymphocytic leukemia nephrotic syndrome acute renal failure minimal-change glomerulonephritis biopsy electron microscopy bendamustine rituximab
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31885

Similar Items

Glomerulonephritis associated with marginal zone B-cell lymphoma: clinical, pathological characteristics of renal injury and treatment (clinical cases)
by: B. T. Dzhumabaeva, et al.
Published: (2015-12-01)

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study
by: S. V. Semochkin, et al.
Published: (2015-06-01)

Chronic lymphocytic leukemia accompanied by renal failure
by: B T Dzhumabaeva, et al.
Published: (2014-12-01)

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
by: Francesco Autore, et al.
Published: (2020-06-01)

Spectrum of Glomerulonephritis in Egypt
by: Barsoum Rashad, et al.
Published: (2000-01-01)

Bendamustine: a new view on treatment of chronic lymphocytic leukemia
by: Ye. A. Nikitin
Published: (2022-11-01)

Idiopathic Reversible Renal Failure in a Young Woman with Minimal Change Glomerulonephritis
by: Malik Tahir, et al.
Published: (2006-01-01)

Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
by: Won Sriwijitalai, et al.
Published: (2019-02-01)

Efficacy of a bendamustine and rituximab combination in first-line therapy for chronic lymphocytic leukemia: Results of the BEN-001 study
by: E A Stadnik, et al.
Published: (2017-07-01)

Treatment Emergent Agranulocytosis with Skin and Gingival Lesions in a Chronic Lymphocytic Leukemia Patient: A Case Report
by: Ramesh Amirisetty, et al.
Published: (2016-10-01)

Biopsy Proven Renal Diseases:Clinicopathological Correlations
by: Sohail Sabir
Published: (2013-12-01)

Ibrutinib versus bendamustine plus rituximab for first-line treatment of 65 or older patients with untreated chronic lymphocytic leukemia without del(17p)/TP53 mutation in China: a lifetime economic research study
by: Yuan Hong, et al.
Published: (2023-12-01)

Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
by: Martina Bogeljić Patekar, et al.
Published: (2018-01-01)

Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis
by: Ester Lovato, et al.
Published: (2023-04-01)

Histomorphologic analysis in adult nephrotic syndrome: Changing scenario
by: Chitrawati Bal Gargade, et al.
Published: (2016-01-01)

The Spectrum of Glomerulopathy in Jordan
by: Said Riyad, et al.
Published: (2000-01-01)

Role of direct immunofluorescence in the diagnosis of glomerulonephritis
by: Archana C Buch, et al.
Published: (2015-01-01)

HLA-PHENOTYPE IN PATIENTS WITH GLOMERULONEPHRITIS WITH VARIOUS MORPHOLOGIC FORMS AND NEPHROTIC SYNDROM
by: M. Kolesnyk, et al.
Published: (2016-04-01)

Efficacy of rituximab in thymoma associated minimal change disease: case report
by: Zhour El Ouafi, et al.
Published: (2021-09-01)

Glomerulonephritis Histopathological Pattern Change
by: Anas AlYousef, et al.
Published: (2020-05-01)

Incidence of glomerulonephritis in the western part of Switzerland over the last decade
by: Giliane Nanchen, et al.
Published: (2020-10-01)

Renal biopsy in Glomerulonephritis
by: Masoud Pezeshki Rad, et al.
Published: (2014-04-01)

Pharmacoeconomic aspects of recurrent / refractory chronic lymphocytic leukemia treatment
by: A. V. Rudakova, et al.
Published: (2020-04-01)

Oral Cryptococcosis in a Patient with Chronic Lymphocytic Leukemia
by: Sachin Patel, et al.
Published: (2016-09-01)

Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
by: Andreas Kronbichler, et al.
Published: (2014-01-01)

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
by: Sara E. F. Kost, et al.
Published: (2019-10-01)

The role of cell signaling molecules in the pathogenesis of glomerulonephritis in children
by: Angela Ciuntu
Published: (2021-06-01)

Spectrum of glomerulonephritis in adult Jordanians at Jordan university hospital
by: Wahbeh Ayman, et al.
Published: (2008-01-01)

Acute Myeloid Leukemia in a Geriatric Patient with a History of Minimal Change Disease
by: Alper Alp, et al.
Published: (2022-11-01)

Recurrent Acute Renal Failure in a Patient with Minimal Change Disease
by: Abdelrahman Mohammad, et al.
Published: (2001-01-01)

Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
by: Karasavvidou Foteini, et al.
Published: (2011-07-01)

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study
by: Antonio Cuneo, et al.
Published: (2020-11-01)

Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease
by: Edoardo Benedetti, et al.
Published: (2023-02-01)

Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility
by: James E, et al.
Published: (2021-03-01)

Minimal change disease versus IgA nephropathy
by: Jabur Wael
Published: (2009-01-01)

Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis
by: Tiantian Ma, et al.
Published: (2022-02-01)

Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review
by: Soo-Jee Jeon, et al.
Published: (2022-07-01)

The Spectrum of Biopsy-Proved Kidney Disease: A Retrospective Single Center Study in Erbil-Iraq
by: Ahmed Al-Imam, et al.
Published: (2019-03-01)

Histologic patterns of primary adult onset nephrotic syndrome and their clinical characteristics; a single center study from South India
by: Gurudev Konana, et al.
Published: (2017-10-01)